Microsoft has introduced Dragon Copilot, an advanced AI-powered voice assistant tailored for the healthcare sector. This innovative tool is designed to enhance clinical efficiency, ease administrative tasks, and improve patient care through cutting-edge voice dictation and ambient listening technology.
Dragon Copilot integrates key features from Dragon Medical One and DAX Copilot—solutions developed by Nuance, which Microsoft acquired in 2021. The AI assistant can automatically generate clinical documentation, search medical databases, and create referral letters and post-visit summaries. Additionally, it supports multilingual ambient note-taking and natural language dictation, making it a highly adaptable tool for healthcare professionals.
Dragon Copilot integrates key features from Dragon Medical One and DAX Copilot—solutions developed by Nuance, which Microsoft acquired in 2021. The AI assistant can automatically generate clinical documentation, search medical databases, and create referral letters and post-visit summaries.
Additionally, it supports multilingual ambient note-taking and natural language dictation, making it a highly adaptable tool for healthcare professionals.
Joe Petro, Microsoft’s Corporate Vice President of Health and Life Sciences Solutions and Platforms, highlighted AI’s transformative role in healthcare. “We strongly believe AI has the power to relieve clinicians of administrative burdens, allowing them to focus more on patient care,” Petro stated.
Built on a secure and modern infrastructure, Dragon Copilot integrates seamlessly with electronic health record (EHR) systems like Epic. It provides a unified experience for clinicians, enabling them to dictate notes, automate routine tasks, and access reliable medical information from sources such as the CDC and FDA.
Early adoption of Dragon Copilot has demonstrated promising outcomes, including reduced clinician burnout and improved patient satisfaction. Microsoft’s surveys indicate that clinicians using the AI tool reported lower stress levels, while 93% of patients experienced a more positive healthcare interaction.
The AI assistant is set to launch in the US and Canada in May, with plans to expand to additional countries, including the UK, Netherlands, France, and Germany.
